Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients-Reference-Cited by-同舟云学术

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

Published:2011-10-14 Issue:1 Volume:107 Page:213-221
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Reardon David A.,Herndon James E.,Peters Katherine,Desjardins Annick,Coan April,Lou Emil,Sumrall Ashley,Turner Scott,Sathornsumetee Sith,Rich Jeremy N.,Boulton Susan,Lipp Eric S.,Friedman Henry S.,Vredenburgh James J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-011-0740-0.pdf

Reference34 articles.

1. van den Bent MJ (2007) Anaplastic oligodendroglioma and oligoastrocytoma. Neurol Clin 25:1089–1109 ix–x

2. See SJ, Gilbert MR (2004) Anaplastic astrocytoma: diagnosis, prognosis, and management. Semin Oncol 31:618–634

3. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC (2006) A t(1; 19)(q10; p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66:9852–9861

4. Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27:5874–5880. doi: 10.1200/JCO.2009.23.6497

5. van den Bent MJ, Dubbink HJ, Sanson M, van der Lee-Haarloo CR, Hegi M, Jeuken JW, Ibdaih A, Brandes AA, Taphoorn MJ, Frenay M, Lacombe D, Gorlia T, Dinjens WN, Kros JM (2009) MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC brain tumor group study 26951. J Clin Oncol 27:5881–5886. doi: 10.1200/JCO.2009.24.1034

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of low-dose bevacizumab on health-related quality of life in patients with recurrent high-grade glioma: A retrospective clinical study;Journal of Clinical Neuroscience;2024-02

2. Targeting tumor microenvironment-associated cells to reverse therapy resistance;New Targeting in the Reversal of Resistant Glioblastomas;2021

3. Activation of nuclear factor‐κB in the angiogenesis of glioma: Insights into the associated molecular mechanisms and targeted therapies;Cell Proliferation;2020-12-10

4. Therapeutic efficacy of specific immunotherapy for glioma: a systematic review and meta-analysis;Reviews in the Neurosciences;2018-06-27

5. Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma;Annals of the Academy of Medicine, Singapore;2015-10-15